Balentine LLC’s Carter's CRI Stock Holding History

Balentine LLC’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15	Closed	-$1K	–	756
2019 Q2	$1K	Buy	+15	New	+$1.46K	﹤0.01%	683

Other funds holding CRI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balentine LLC's CRI Position: Q3 2019 in Review

Balentine LLC sold out of Carter's (CRI) in Q3 2019, closing a stake of 15 shares — an estimated $1K sold.

Balentine LLC first reported a position in CRI in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 285 funds tracked by Wall St. Rank hold CRI as of Q3 2019.

Balentine LLC reported no remaining Carter's position as of Q3 2019 after selling out during the quarter.
Balentine LLC sold 15 Carter's shares in Q3 2019, an estimated $1K.
Balentine LLC first reported a position in Carter's in Q2 2019 and held it in 1 quarter.
Balentine LLC's Carter's position peaked at $1K in Q2 2019.
285 funds tracked by Wall St. Rank held Carter's as of Q3 2019.

Based on Balentine LLC's 13F filing for Q3 2019, filed 15 Nov 2019.